ArticleBlood advances2026

DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.

Lonneke J Verboon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.